Gilead Sciences Inc

Founded in 1987 Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides the building blocks of DNA and RNA in the United States The company discovers develops and commercializes medications to advance the care of patients suffering from lifethreatening diseases Headquartered in Foster City Calif it serves North America Europe and Australia and employs a staff of more than 3400 individuals Gilead Sciences areas of focus include antivirals such as HIVAIDS and chronic hepatitis as well as cardiovascular conditions including pulmonary arterial hypertension and resistant hypertension The company also conducts studies on various respiratory diseases such as influenza and cystic fibrosis

Gilead Sciences Inc, founded in 1987, is a leading discovery and development company focused on a new class of human therapeutics built on nucleotides—the essential building blocks of DNA and RNA. The company advances care for patients facing life-threatening diseases by discovering, developing, and commercializing medications across multiple therapeutic areas. While Gilead is headquartered in Foster City, California, it serves major international markets, including North America, Europe, and Australia, and employs a staff of more than 3,400. In its work, Gilead emphasizes antivirals such as HIV/AIDS and chronic hepatitis, as well as cardiovascular conditions including pulmonary arterial hypertension and resistant hypertension. The company also conducts studies in respiratory diseases, including influenza and cystic fibrosis. For readers and organizations in Miami, Florida looking for a professional consulting directory listing connected to cutting-edge life sciences and therapeutics expertise, Gilead Sciences represents a long-standing, research-driven leader in human medication development.